GeneDx plans to launch long-read whole genome sequencing for rare disease testing, with an early access program expected by ...
CDC reports early-season influenza activity is above average for November, with H1N1 dominating lab detections.
Ultima Genomics introduces paired-end sequencing and Solaris 2.0 Max consumables, enabling $60 genome and doubling output.
Bio-Rad adds new ddPCR assays, reagents and technologies for QX700 systems, expanding multiplex cancer mutation and biomarker ...
New England Biolabs will present new multiomic cell-free DNA and RNA workflows, enzymatic methylation profiling, and a PCR ...
FDA grants Breakthrough Device Designation to Primaa’s Cleo Skin AI pathology tool, which now has both CE-IVDR and FDA status ...
Labcorp has completed its acquisition of Millennium Health, expanding its national toxicology testing network.
Siemens Healthineers will separate its in vitro diagnostics business as Olyrian Diagnostics, aiming to complete the ...
Agilent has acquired digital pathology software firm Proscia for $240 million, adding an FDA-cleared platform to its ...
Thermo Fisher Scientific introduces AmpSure Universal SYBR Green and Probe Master Mixes, offering value-priced qPCR reagents.
A study links early donor-derived cell-free DNA patterns to kidney transplant outcomes, including rejection and graft loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results